ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,892Medicare Part D Prescriptions Filled, Including Refills

Rank: 163 out of 337

$398K Total Retail Price of All Prescriptions

Rank: 111 out of 337

311 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 311 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 311 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 4,691 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 321 247 1 1
AMLODIPINE BESYLATE 251 226 2 3
LEVOTHYROXINE SODIUM 224 200 3 5
FUROSEMIDE 197 176 4 8
OMEPRAZOLE 160 124 5 4
LISINOPRIL 158 124 6 2
METFORMIN HCL 128 83 7 12
LOSARTAN POTASSIUM 120 78 8 15
ATORVASTATIN CALCIUM 111 86 9 7
METOPROLOL TARTRATE 108 104 10 6
HYDROCHLOROTHIAZIDE 108 78 10 9
ALENDRONATE SODIUM 94 94 12 19
AMLODIPINE BESYLATE-BENAZEPRIL 83 83 13 97
BENAZEPRIL HCL 79 76 14 109
METOPROLOL SUCCINATE 76 67 15 21
ATENOLOL 74 69 16 10
GLIPIZIDE ER 70 47 17 69
CITALOPRAM HBR 70 52 17 17
WARFARIN SODIUM 70 58 17 11
GABAPENTIN 69 58 20 20
IBUPROFEN 68 31 21 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 54 22 31
LOVASTATIN 66 66 23 24
CRESTOR 65 62 24 29
DIOVAN 65 49 24 26
DIOVAN HCT 64 53 26 88
LOSARTAN-HYDROCHLOROTHIAZIDE 62 56 27 60
NEXIUM 61 33 28 56
FENOFIBRATE 60 57 29 48
ISOSORBIDE MONONITRATE ER 59 54 30 70
FLUTICASONE PROPIONATE 58 27 31 34
TRAMADOL HCL 53 31 32 32
ZOLPIDEM TARTRATE 50 39 33 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.